KabaFusion Selected by UCB as a Limited Distribution Partner
August 2, 2023 –
KabaFusion, a nationally recognized leader in home infusion, has been selected by UCB as a limited distribution partner to provide RYSTIGGO® (rozanolixizumab-noli).
KabaFusion Selected by UCB as a Limited Distribution Partner Read More »